biotech Articles - Page 3 of 9 - Perficient Blogs
Blog

Posts Tagged ‘biotech’

  • Topics
  • Industries
  • Partners

Explore

Topics

Industries

Partners

Top 10 Life Sciences Blog Posts Of 2016

While we rolled into 2017, I thought it would be neat to see what our readers were, well, reading. Without further ado, here are the top 10 blog posts Perficient’s life sciences practice wrote that seemed to be popular among readers. They’re ranked in order of popularity, with number one being the most viewed piece. The 8 […]

Read more

Using Digital Technology In Post-Market And Real-World Contexts

Digital technology has applications throughout clinical studies, from recruitment through data collection. But, it is also being used in exciting and meaningful ways once a drug or device has gone to market, both to improve patient outcomes and to keep sponsors informed. Below are a couple of examples. Huggable, a teddy bear developed by Dr. […]

Read more

Capturing Clinical Data With Connected Health Technology

The area of clinical data collection has seen an influx of rich, digital solutions in recent years, and more continue to enter the marketplace. The plethora of devices, apps, and solutions is aiding in data collection – some within the context of clinical trials and healthcare, others for patients themselves as users and owners of […]

Read more

Capturing Informed Consent With Digital Technology

One key area in clinical trials that could benefit from connected health digital solutions is capturing informed consent. Traditionally, patients have signed informed consent forms that are very text-heavy, yet they don’t really understand the rights, responsibilities, risks, and benefits of the study. Explaining the complex details of a trial can add a significant amount […]

Read more

Applying Connected Health Concepts To Subject Recruitment

In the area of subject recruitment, there are several new technologies that focus on making it easier for companies to recruit, such as reaching a wider population directly for recruitment. Initially, recruitment was handled mostly by physicians and their patients; however reaching patients directly is proving to be very fruitful. One example of a company […]

Read more

Why Should Life Sciences Care About “Going Digital?”

It seems every company in every industry is talking about “going digital,” but to understand the landscape of life sciences, we must first understand some of the shifts within healthcare that are driving change. Below are some trends that are reshaping healthcare and, therefore, life sciences, and are making it harder and harder for life […]

Read more

Sites Ask Sponsors And CROs, “Where’s The Love?”

According to the 2016 Summit Site Landscape Survey, which was conducted by the Society for Clinical Research Sites, the majority of clinical sites aren’t feeling the love from sponsors and CROs. Of the 463 survey respondents, only 31% felt their relationship with sponsors had improved in the past two years, and only 25% felt that […]

Read more

Top 5 Life Sciences Blog Posts From November 2016

Now that December is here, I thought it would be neat to look back at what our readers found most interesting last month. Below are the top five blog posts Perficient’s life sciences practice wrote in November – they’re ranked in order of popularity, with number one being the most viewed piece. 10 Headlines That Suggest Donald Trump […]

Read more

Eli Lilly Launched 50+ Apps On Salesforce

As one of Salesforce’s strategic partners, I’m glad to share the success Eli Lilly is having with the Salesforce platform. According to a press release that was issued by Salesforce, the pharmaceutical company has launched 50+ internal and external applications over the last two years. TrialGuide is one example. The website, which is naturally mobile-friendly, […]

Read more

10 Headlines That Suggest Donald Trump Is Good For Pharma

This year’s presidential election invoked serious fear in the pharmaceutical industry, with the cost of drugs taking center stage for a good portion of some candidates’ campaigns. While what candidates say they’ll do could very well be different than what they’ll try to do, their words and records are enough to push pundits, investors, and […]

Read more

Will We See More Advertising From Pharma On Facebook?

Bayer recently launched its first Facebook ad. The ad also happens to be the first time Facebook has allowed a company to put important safety information (ISI) in a scrolling format, something that pharmaceutical companies have long been able to do in banner ads. In addition, the social media giant is also enabling drug companies […]

Read more

Top 5 Life Sciences Blog Posts From October 2016

Now that November is here, I thought it would be neat to look back at what our readers found most interesting last month. Below are the top five blog posts Perficient’s life sciences practice wrote in October – they’re ranked in order of popularity, with number one being the most viewed piece. Pharma Reps Continue To Struggle […]

Read more

Pharma Reps Continue To Struggle To Get Face Time With Physicians

A new study found that pharmaceutical sales reps are finding it more difficult to meet with physicians in person. Compared to 2008, when nearly 80% of physicians agreed to meet with most reps, now: 44% of physicians are “accessible,” meaning they meet with more than 70% of sales reps who pursue them 38% of physicians […]

Read more

[Next Week] Incorporating Digital Tech Into Clinical Trials

Innovative mobile technologies are continuously being introduced, and savvy life sciences organizations are taking note. Many of these technologies have the potential to drastically reduce the time and cost of clinical trials, from subject recruitment to data collection, not to mention likely create a boost in patient engagement. Examples of using digital technologies in clinical […]

Read more

How Jazz Uses Connected Health To Create Awareness And Demand

A recent conversation with a prospective client of ours prompted me to write this post. The client is looking at ways to improve the adoption rate of one of its products by a specific population because, for a variety of reasons, adoption by that segment has been slower than others. The solution to challenges like […]

Read more

What Connected Health For Life Sciences Means For You

It seems every company in every industry is talking about “going digital.” But, what does that really mean? At its heart, going digital is really just about relationships: relationships with customers, partners, team members, and the world at large. Since the introduction of mobile and digital technology, the ways in which we interact with others […]

Read more

What Are The Implications Of Not Complying With E2B(R3)?

In the European Union, the use of E2B(R3), along with IDMP, is in legislation, so not complying by the deadline could have legal repercussions. Non-compliance with the FDA and MHLW’s requirements could also bring unwanted scrutiny. More importantly, if an organization does not comply by the deadlines, they will not be able to send ICSRs […]

Read more

Do Commercially Available Safety Systems Comply With E2B(R3)?

Yes, some validated systems can comply with E2B(R3). With respect to Oracle Argus Safety, the current version, 8.0.1, is able to comply with E2B(R3), Electronic Vaccine Adverse Event Reporting System (eVAERS), and Electronic Medical Device Reporting (eMDR) reporting requirements. If a company is simply looking to meet E2B(R3) requirements, we advise waiting to upgrade until […]

Read more

Top 5 Life Sciences Blog Posts From July 2016

Now that August is here, I thought it would be neat to look back at what our readers found most interesting last month. Below are the top five blog posts Perficient’s life sciences practice wrote in July – they’re ranked in order of popularity, with number one being the most viewed piece. When Do Companies Have To […]

Read more

Subscribe to the Weekly Blog Digest:

Sign Up